drugset / Trial / NCT04756648
Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma
Phase 1
Active not recruiting
21 enrolled
Zhejiang University
CARsgen Therapeutics Co., Ltd. · collab
NaSequentialOpen-labelTreatment
Summary
A Phase I Clinical Study ofCT0180 cells in Patients with Advanced Hepatocellular Carcinoma
Timeline
- Start
- 2021-03-10
- Primary completion
- 2023-03-31
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CT0180 | Cell therapy | — | — |